Filters

Latest News

2022-04-26 17:00:48

Celebrating World IP Day with a focus on youth and innovation

Geneva, 26 April 2022 – On World Intellectual Property (IP) Day, the International Federation of Pharmaceutical Manufacturers and Associations (IFPMA) ...

Read More

2022-04-13 12:45:21

COVID-19 vaccines and treatments output continues apace; as health systems and last mile hurdles remain collective stumbling blocks

To date, over 13 billion doses of COVID-19 vaccines have been produced and 11 billion ...

Read More

2022-04-04 13:49:50

Largest pharmaceutical industry-backed collective venture fund tackling antimicrobial resistance announces first portfolio investments

April 4, 2022, Geneva – The international trade body representing the biopharmaceutical industry (IFPMA) today ...

Read More

2022-02-25 07:30:32

Three priorities to urgently increase access to COVID-19 vaccines

Innovative biopharmaceutical companies are at the forefront of the global effort to develop and manufacture ...

Read More

2022-02-01 13:00:37

Taking action on AMR: Largest life sciences sector coalition shows leadership in R&D, appropriate use and access to antibiotics and responsible manufacturing

1 February 2022 (Geneva) – Today the AMR Industry Alliance released its latest Progress Report, ...

Read More

2021-12-16 11:41:08

11 billion COVID-19 vaccines produced in 2021 has resulted in the biggest immunization campaign in human history and 2022 will require more and better vaccine redistribution and innovation

A year since the first COVID-19 vaccine was administered, vaccine makers including biotechnology firms, developing ...

Read More

2021-12-03 15:07:32

Global pharmaceutical industry leaders meet with UK Prime Minister to discuss leadership in global health and innovation

London, 3  December, 2021 – Yesterday, global leaders from the pharmaceutical industry met with the ...

Read More

Latest Statement

2022-05-10 16:56:42

Open Letter on ACT-A Therapeutics and Ongoing Roadblocks to Enhancing Access

A number of global health stakeholders are asserting that the supply of COVID-19 therapeutics is a challenge globally, and that ...

Read More

2022-05-10 12:25:38

IFPMA statement on Quad’s Outcome Document on TRIPS

London, 3  December, 2021 – Yesterday, global leaders from the ...

Read More

2022-04-13 14:44:10

Introductory remarks by Thomas Cueni at IFPMA media briefing on 13 April 2022

London, 3  December, 2021 – Yesterday, global leaders from the ...

Read More

2022-04-13 08:24:02

IFPMA statement at public hearings regarding a new international instrument on pandemic preparedness and response

London, 3  December, 2021 – Yesterday, global leaders from the ...

Read More

2022-04-12 01:00:56

IFPMA comment on draft guidance on value of new antibiotics as part of UK “subscription-type” payment model

London, 3  December, 2021 – Yesterday, global leaders from the ...

Read More

2022-03-21 17:31:48

Joint Industry Statement on the War in Ukraine

London, 3  December, 2021 – Yesterday, global leaders from the ...

Read More

2022-03-16 11:29:09

IFPMA statement on TRIPS discussion document

London, 3  December, 2021 – Yesterday, global leaders from the ...

Read More

mailto:a.jones@ifpma.org

Abigail Jones - Director, Communications

Abigail Jones is responsible for communications at IFPMA. She joined IFPMA after over 25 years in international communications and public affairs consultancy, where she worked for many blue-chip companies, trade associations, think tanks, coalition and advocacy groups. Abigail supported the launches and ongoing work of the Fight the Fakes campaign, AMR Industry Alliance and Pat-INFORMED.

mailto:m.depol@ifpma.org
Twitter @MorganePol

Morgane De Pol - Deputy Director, Communications

Morgane develops and implements public affairs programs that build trust, dialogue and collaboration between the innovative biopharmaceutical industry and other global players in the health community. Morgane has international experience in developing and rolling-out integrated advocacy and communications strategies in the global health sector, with specific focus on institutional communications, media relations, alliance building and event management.

A shared commitment to global health

Our Brouchure

2015 Edition

A shared commitment to global health

At IFPMA we advocate policies and practices that encourage the discovery of and access to life-saving and life-enhancing medicines and vaccines, for people everywhere.


Our Logo

Full colour EPS format

Our Logo

Full colour PNG format


FULL Name LOGO

Full colour EPS format


FULL Name LOGO

Full colour PNG format

News Release

meeting-discusses-covid-19-vaccine-manufacturing-bottlenecks-that-must-be-urgently-tackled-for-c19-vaccine-output-to-reach-its-full-potential

Meeting discusses COVID-19 vaccine manufacturing bottlenecks that must be urgently tackled for C19 vaccine output to reach its full potential

9 March 2021: Chatham House, in collaboration with COVAX, IFPMA, DVCMN, and BIO, convened a Global COVID-19 Vaccine Supply Chain & Manufacturing Summit on 8th and 9th March. The unprecedented scaling up of vaccine manufacturing, from zero to billions of

Read More

Our Blog

Latest Tweets

Improving health outcomes for people living w/ cancer in LLMICs is a must. But ‘same old’ ways of working won't ach… https://t.co/lOqAbnPuJL
1
As demonstrated in a recent @TheLancet study, #AntimicrobialResistance (AMR) killed over 1.2 million people around… https://t.co/JTaE6AcKCt
1
We are committed to cultivating #ClinicalResearch representative of those it serves. Join us in a webinar discussi… https://t.co/ARktN5zcwf
1 5
After the loss of my mum to #cervicalcancer, I’m proud to play my part in improving access to potentially life-savi… https://t.co/SnV0Gdgk5R
2 4